wide ranging broker views on qrx-any thoughts?, page-5

QRX sophisticated and institute investors placement has been oversubscribed, raised 50% more than the initial plan's. Only $2.5m SPP is current under way.

Delay of FDA approval, sp has been halved, from $1.37 to $0.60. Last time, sp sharply dropped to 50c, then bounced to 90ish, steadily @68-75c, then went back over $1 on expectation of FDA approval.

Currently, we have $16m cash plus $2.5m from SPP, sufficient for next 15 months. I expect QRX steadily climbing back $1.